EMA warns of shortages of two Boehringer heart drugs due to a spike in demand
The EMA is putting EU member states on alert over the shortage of two drugs that counter heart attacks due to an uptick in demand …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
